Use of heptaminol hydrochloride for catecholamine weaning in septic shock

American Journal of Therapeutics

Volumn 19, Issue 1, 2012, Pages

  Bahloul, Mabrouk ^a   Chaari, Anis ^a   Mbarek, Mohamed Nouri Ben ^a   Kallel, Hatem ^a   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

catecholamine weaning; heptaminol hydrochloride; septic shock

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BICARBONATE; DOBUTAMINE; DOPAMINE; HEPTAMINOL; HYDROCORTISONE; NORADRENALIN;

ADJUVANT THERAPY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOXIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SIDE EFFECT; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

ADULT; AGED; DOPAMINE; FEMALE; HEPTAMINOL; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 84855642608     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181e9b630     Document Type: Article

References (19)

1. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006;34:589-597.
2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17-60.
3. Rivers ER, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.
4. Merouani M, Guignard B, Vincent F, et al. Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic. Crit Care. 2008;12:R155.
5. Pourrias B. Heptaminol chlorhydrate: new data. Ann Pharm Fr. 1991;49:127-138.
6. Chanoine F, Benedetti MS, Ancher JF, et al. Absorption, distribution, elimination and metabolism of 14C-heptaminol hydrochloride in rat. Arzneimittelforschung. 1981;31: 1430-1435. (Pubitemid 11057275)
7. Qureshi SS, Lewis SM, Gant VA, et al. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol. 2001;125:258-265. (Pubitemid 32758437)
8. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270: 2957-2963. (Pubitemid 24000804)
9. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE: Acute Physiology and Chronic Health Evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591-597.
10. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med. 1991;114:332-333.
11. de Jong MFC, Beishuizen A, Groeneveld ABJ. Defining relative adrenal insufficiency in the critically ill: the ACTH test revisited. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Heidelberg: Springer 2006 539-550
12. Annane D, Bellisant E, Cavaillon JM. Septic shock, Lancet. 2005;365:63-78.
13. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone in patients with septic shock. JAMA. 2002;288: 862-871.
14. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 hours after a single dose of etomidate. Anaesthesia. 1999;54:861-867. (Pubitemid 29415418)
15. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30:536-555. (Pubitemid 38541501)
16. Ligtenberg JJM, Zijlstra JG. The relative adrenal insufficiency syndrome revisited: which patients will benefit from low-dose steroids. Curr Opin Crit Care. 2004;10:456-460. (Pubitemid 39620194)
17. Raurich JM, Llompart-Pou JA, Ibáñez J, et al. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients. J Crit Care. 2007;22:324-329.
18. Milon D, Allain H, Reymann JM, et al. Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians. Fundam Clin Pharmacol. 1990;4: 695-705.
19. Delicado EG, Fideu MD, Miras-Portugal MT, et al. Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells. Biochem Pharmacol. 1990;40:821-825. (Pubitemid 20246591)